(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices) | (Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a–12 under the Exchange Act (17 CFR 240.14a–12) |
Pre–commencement communications pursuant to Rule 14d–2(b) under the Exchange Act (17 CFR 240.14d–2(b)) |
Pre–commencement communications pursuant to Rule 13e–4(c) under the Exchange Act (17 CFR 240.13e–4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Sesen Bio, Inc. | ||||||||
By: | /s/ Thomas R. Cannell, D.V.M. | |||||||
Thomas R. Cannell, D.V.M. | ||||||||
President and Chief Executive Officer |
Cover |
Jul. 21, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Entity Registrant Name | SESEN BIO, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-36296 |
Entity Tax Identification Number | 26-2025616 |
Entity Address, Address Line One | 245 First Street |
Entity Address, Address Line Two | Suite 1800 |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02142 |
City Area Code | 617 |
Local Phone Number | 444-8550 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 |
Trading Symbol | SESN |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001485003 |
Amendment Flag | false |
Document Period End Date | Jul. 17, 2022 |
-8?20$3;8T.P6BP^0"X99K>]9!:G
M